These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29501606)

  • 1. Amyloid growth and membrane damage: Current themes and emerging perspectives from theory and experiments on Aβ and hIAPP.
    Sciacca MFM; Tempra C; Scollo F; Milardi D; La Rosa C
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1625-1638. PubMed ID: 29501606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single mutation on the human amyloid polypeptide modulates fibril growth and affects the mechanism of amyloid-induced membrane damage.
    Hoffmann ARF; Saravanan MS; Lequin O; Killian JA; Khemtemourian L
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1783-1792. PubMed ID: 29499190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranes as modulators of amyloid protein misfolding and target of toxicity.
    Rawat A; Langen R; Varkey J
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1863-1875. PubMed ID: 29702073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
    Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
    Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
    Sellin D; Yan LM; Kapurniotu A; Winter R
    Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides.
    Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J
    ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent computational studies of membrane interaction and disruption of human islet amyloid polypeptide: Monomers, oligomers and protofibrils.
    Dong X; Qiao Q; Qian Z; Wei G
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1826-1839. PubMed ID: 29530482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
    Ge X; Yang Y; Sun Y; Cao W; Ding F
    ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide.
    Yan LM; Velkova A; Kapurniotu A
    Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human IAPP amyloidogenic properties and pancreatic β-cell death.
    Fernández MS
    Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Understanding of Aβ-hIAPP Cross-Seeding Assemblies on Lipid Membranes.
    Zhang M; Hu R; Ren B; Chen H; Jiang B; Ma J; Zheng J
    ACS Chem Neurosci; 2017 Mar; 8(3):524-537. PubMed ID: 27936589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis?
    Zhang Y; Song W
    Prog Neurobiol; 2017 Jun; 153():100-120. PubMed ID: 28274676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired peripheral glucose homeostasis and Alzheimer's disease.
    Wijesekara N; Gonçalves RA; De Felice FG; Fraser PE
    Neuropharmacology; 2018 Jul; 136(Pt B):172-181. PubMed ID: 29169962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer's disease: two triggers, one disease.
    Ferreira S; Raimundo AF; Menezes R; Martins IC
    Neural Regen Res; 2021 Jun; 16(6):1127-1130. PubMed ID: 33269760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
    Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
    ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.
    Sasahara K; Morigaki K; Okazaki T; Hamada D
    Biochemistry; 2012 Sep; 51(35):6908-19. PubMed ID: 22876830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking Inflammasome Activation Caused by β-Amyloid Peptide (Aβ) and Islet Amyloid Polypeptide (IAPP) through an IAPP Mimic.
    Aftabizadeh M; Tatarek-Nossol M; Andreetto E; El Bounkari O; Kipp M; Beyer C; Latz E; Bernhagen J; Kapurniotu A
    ACS Chem Neurosci; 2019 Aug; 10(8):3703-3717. PubMed ID: 31295403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Seeding Interaction between β-Amyloid and Human Islet Amyloid Polypeptide.
    Hu R; Zhang M; Chen H; Jiang B; Zheng J
    ACS Chem Neurosci; 2015 Oct; 6(10):1759-68. PubMed ID: 26255739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.